Angiosarcoma of the scalp

What is the outlook (prognosis) for angiosarcoma of the scalp?

Angiosarcoma of the scalp is considered an aggressive cancer with an unfavorable prognosis. Without treatment,
the original tumor typically increases in size and may bleed or form an open sore (ulcer). Eventually, the tumor is likely to spread (metastasize) into nearby tissues or to other parts of the body, such as the lungs. The progression of this condition depends on the initial size of the tumor and whether there are multiple spots (multifocal lesions). Studies have found that, even with treatment, half of affected individuals survive for 15 to 22 months following diagnosis, and approximately one third survive for five years.

Last updated on 05-01-20

How many people have angiosarcoma of the scalp?

Angiosarcoma of the scalp accounts for less than 1 percent of all sarcomas. Only about 0.5 people per 1,000,000 develop angiosarcoma in the US.

Last updated on 05-01-20

Where To Start


The Sarcoma Foundation of America provides general information about angiosarcoma. Click on the link to access this information.

Last updated on 04-27-20

Name: Sarcoma Foundation of America PO Box 98160
Washington, DC, 20090-8160, United States
Phone: +1-301-253-8687 Fax : +1-301-253-8690 Email: Url:
Zager JS. Angiosarcoma of the scalp Medscape. 2013; Reference Link Fujisawa Y, Yoshino K, Fugimura T, Nakamura Y, Okiyama N, Ishitsuka Y et al. Cutaneous angiosarcoma: The possibility of new treatment options especially for patients with large primary tumor Front Oncol. Mar 2018; 8(46). epub. Reference Link Spiker AM, Ramsey ML. Cancer, Angiosarcoma StatPearls. Updated Jan 24, 2019; Reference Link Bhatti Z, Bhatti R, Brangman S, Whiting K, Dhamoon A. Extensive cutaneous scalp angiosarcoma Case Rep Dermatol Med. Jun, 2018; 1-3. Reference Link

Connect with other users with Angiosarcoma of the scalp on the RareGuru app

Do you have information about a disease, disorder, or syndrome? Want to suggest a symptom?
Please send suggestions to RareGuru!

The RareGuru disease database is regularly updated using data generously provided by GARD, the United States Genetic and Rare Disease Information Center.

People Using the App

Join the RareGuru Community

To connect, share, empower and heal today.

People Using the App